PreciVax Therapeutics

PreciVax Therapeutics is developing innovative vaccines for drug-resistant bacterial infections. The company first launched its product which is a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).

Company NamePreciVax Therapeutics
Brand NamePreciVax Therapeutics
Year of Establishment2017
Founder(s)Qiubin LIn
No. of Employees1-10
Regional CoverageHong Kong
Fundraising History/
Raising Fund/
Fundraising target/
Pre-money valuation/
Post-money Valuation/
Media Exposure
Company Email

This is the beta version, if there is any mistake, please fill in the form to update your information.

Hong Kong Startup Directory is sponsored by T12M Ventures Limited.

想知道更多林老師的創業及數碼推廣秘技?快點關注我們的Facebook Page吧!

Leave a Comment